• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Emergent Biosolutions (EBS)

Common Stock
Sell: $12.45|Buy: $13.07|Change: 0.09 (0.72%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segmentwhich consists of NARCAN and other commercial products.

Address

300 Professional Drive
Gaithersburg
MD
USA
20879

Telephone

+1 240 6313360

Website

https://www.emergentbiosolutions.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Emergent BioSolutions Inc Third Quarter Earnings Conference Call for 20262026-10-29T17:00:00
Emergent BioSolutions Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00
Emergent BioSolutions Inc Second Quarter Earnings Conference Call for 20262026-08-06T17:00:00
Emergent BioSolutions Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Emergent BioSolutions Inc First Quarter Earnings Conference Call for 20262026-05-07T17:00:00
Emergent BioSolutions Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
Emergent BioSolutions Inc Annual General Meeting for 20262026-04-30T09:00:00
Emergent BioSolutions Inc Annual Report for 20252026-03-04T00:00:00
Emergent BioSolutions Inc Fourth Quarter Earnings Conference Call for 20252026-03-03T17:00:00
Emergent BioSolutions Inc Fourth Quarter Earnings Results for 20252026-03-03T00:00:00

Previous key dates

NameKey Date
Emergent BioSolutions Inc Third Quarter Earnings Conference Call for 20252025-10-29T17:00:00
Emergent BioSolutions Inc Third Quarter Earnings Results for 20252025-10-29T00:00:00
Emergent BioSolutions Inc Second Quarter Earnings Conference Call for 20252025-08-06T17:00:00
Emergent BioSolutions Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
efferies Global Healthcare Conference2025-06-05T13:25:00
BC Global Healthcare Conference2025-05-20T15:35:00
Emergent BioSolutions Inc First Quarter Earnings Conference Call for 20252025-05-07T17:00:00
Emergent BioSolutions Inc First Quarter Earnings Results for 20252025-05-07T00:00:00
Emergent BioSolutions Inc Annual General Meeting for 20252025-04-30T09:00:00
Emergent BioSolutions Inc Annual Report for 20242025-03-04T00:00:00
Emergent BioSolutions Inc Fourth Quarter Earnings Conference Call for 20242025-03-03T17:00:00
Emergent BioSolutions Inc Fourth Quarter Earnings Results for 20242025-03-03T00:00:00
J.P. Morgan's 2025 Leveraged Finance Conference2025-02-24T11:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T13:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.